← Back to Search

Behavioural Intervention

Dietary Intervention for Melanoma

Phase 1
Recruiting
Led By Jennifer McQuade
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying the effects of two different diets on patients with a history of melanoma. One diet is rich in whole foods and fiber, while the other is a ketogenic diet. Participants will be provided all food for the six-week study, but will need to come in for initial screening and blood tests every two weeks.

Who is the study for?
This trial is for melanoma patients with no current disease, resected within the last 5 years. Participants must have a BMI of 18.5-40, normal kidney and liver function tests, fasting glucose under 125 mg/dL, and not be pregnant. They should agree to eat only provided diets and attend scheduled visits in Houston, TX.
What is being tested?
The study compares the effects of two diets on individuals with a history of melanoma: a whole-foods, fiber-rich diet versus a ketogenic diet. Participants will receive free food for six weeks and undergo regular blood tests to monitor changes.
What are the potential side effects?
While specific side effects are not listed for dietary interventions, participants may experience changes in digestion or energy levels due to alterations in their usual eating habits.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of conducting a controlled feeding study in melanoma patients

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group II (ketogenic diet)Experimental Treatment2 Interventions
Patients consume a high fat, low carbohydrate (ketogenic) diet for 6 weeks.
Group II: Group I (fiber-rich diet)Experimental Treatment2 Interventions
Patients consume a whole-foods, fiber-rich diet for 6 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dietary Intervention
2014
Completed Phase 2
~2550

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,066 Previous Clinical Trials
1,802,225 Total Patients Enrolled
108 Trials studying Melanoma
25,969 Patients Enrolled for Melanoma
National Cancer Institute (NCI)NIH
13,920 Previous Clinical Trials
41,017,073 Total Patients Enrolled
564 Trials studying Melanoma
191,204 Patients Enrolled for Melanoma
Jennifer McQuadePrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
50 Total Patients Enrolled
1 Trials studying Melanoma
50 Patients Enrolled for Melanoma

Media Library

Dietary Intervention (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03950635 — Phase 1
Melanoma Research Study Groups: Group I (fiber-rich diet), Group II (ketogenic diet)
Melanoma Clinical Trial 2023: Dietary Intervention Highlights & Side Effects. Trial Name: NCT03950635 — Phase 1
Dietary Intervention (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03950635 — Phase 1
~0 spots leftby Nov 2024